Contracts › 75F40126F19003
75F40126F19003: Eo 14398 - Purchase of Human Induced Pluripotent Stem Cell-Derived (HIPSC) Cells.
Awarded to Fujifilm Biosciences Inc. by Food and Drug Administration (FDA).
$145Kobligated
$145Kpotential value
29 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40126F19003 |
|---|---|
| Vehicle | 75F40125D00013 |
| Awardee | Fujifilm Biosciences Inc. |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 325414 Biological Product (Except Diagnostic) Manufacturing |
| PSC | B529 Special Studies/Analysis- Scientific Data |
| Place of performance | MD |
| Period of performance | 30 September 2026 to 29 September 2027 |
| Potential end | 29 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325414 contracts · All expiring contracts · USASpending record